Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · Real-Time Price · USD
6.76
+0.46 (7.30%)
At close: May 8, 2025, 4:00 PM
6.71
-0.05 (-0.74%)
After-hours: May 8, 2025, 7:59 PM EDT
DAWN Market Cap
DAWN has a market cap or net worth of $685.21 million as of May 8, 2025. Its market cap has decreased by -49.01% in one year.
Market Cap
685.21M
Enterprise Value
215.11M
1-Year Change
-49.01%
Ranking
Category
Stock Price
$6.76
Market Cap Chart
Since the IPO on May 27, 2021, DAWN's market cap has decreased from $965.40M to $685.21M, a decrease of -29.02%. That is a compound annual growth rate of -8.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2025 | 638.58M | -50.02% |
| Dec 31, 2024 | 1.28B | 0.54% |
| Dec 29, 2023 | 1.27B | -19.71% |
| Dec 30, 2022 | 1.58B | 51.68% |
| Dec 31, 2021 | 1.04B | 8.09% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 695.85B |
| Johnson & Johnson | 371.67B |
| UnitedHealth Group | 359.09B |
| AbbVie | 331.06B |
| Novo Nordisk | 297.73B |
| Abbott Laboratories | 231.50B |
| AstraZeneca | 221.83B |
| Novartis AG | 220.92B |